NCT07604389 AR Health Education Video for Postoperative Breast Cancer Patients
| NCT ID | NCT07604389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tungs' Taichung Metroharbour Hospital |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-06-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-06-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Breast cancer surgery patients may experience anxiety and depression before and after surgery. Health education can help patients understand the surgical process and postoperative care, but traditional education may not always be easy to understand. This study evaluates whether augmented reality (AR) health education videos can help reduce anxiety and depression in postoperative breast cancer patients. Participants are randomly assigned to one of two groups. One group receives routine health education plus AR health education videos, and the other group receives routine health education only. The study compares changes in anxiety, depression, and selected physiological indicators between the two groups before and after surgery.
Eligibility Criteria
Inclusion Criteria: * Female patients aged 18 years or older with breast cancer. * Breast cancer confirmed by pathological examination. * Conscious and able to communicate in Mandarin or Taiwanese. * No visual or hearing impairment. * Willing to participate in this study and provide informed consent. Exclusion Criteria: * Patients with brain metastasis, dementia, or cognitive impairment. * Patients currently taking antidepressants, anxiolytics, or other psychiatric medications. * Patients diagnosed with psychiatric disorders. * Patients with a history of hypertension.
Frequently Asked Questions
Who can join the NCT07604389 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07604389 currently recruiting?
Yes, NCT07604389 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tungs' Taichung Metroharbour Hospital to inquire about joining.
Where is the NCT07604389 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07604389 clinical trial?
NCT07604389 is sponsored by Tungs' Taichung Metroharbour Hospital. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.